Compare
Alkermes vs Merck & (ALKS vs MRK)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Alkermes (ALKS) returned +47.7% and Merck & (MRK) +73.9%; so far this year the figures are +64.0% and +39.4%.
Merck & is the larger company by market value, about 46.9 times the size of Alkermes.
Revenue grew +15.3% at ALKS and +4.9% at MRK over the last year.
ALKS pays no dividend. MRK yields 2.32%.
Data as of the latest close. Not investment advice.
Relative performance
| ALKS | MRK | |
|---|---|---|
| Price | $45.90 | $146.73 |
| 1-day | +3.05% | -0.14% |
| YTD | +64.05% | +39.40% |
| 1 year | +47.73% | +73.87% |
| 3 years | +87.04% | +42.66% |
| Market cap | $7.7B | $361.7B |
| P/E | — | 149.7 |
| P/S | 4.40 | 5.37 |
| P/B | 4.14 | 8.06 |
| Revenue growth | +15.30% | +4.90% |
| EPS growth | -101.00% | -87.10% |
| Gross margin % | 82.9 | 71.8 |
| Net margin % | -0.0 | 3.6 |
| ROE % | -0.0 | 5.5 |
| Debt / equity | 0.80 | 1.20 |
| FCF yield % | 2.9 | 4.1 |
| Dividend yield % | — | 2.32 |
| Beta | 0.75 | 0.18 |
| RSI (14) | 59.9 | 51.3 |
| Technical rating |